SciELO - Scientific Electronic Library Online

 
vol.39 issue3Diaphragmatic Rehabilitation Therapy for the Management of Supragastric Belching: Case Series and Literature ReviewEpidemiology of Acute Cholecystitis in Colombia: An Analysis of Official Records from the Ministry of Health author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Revista colombiana de Gastroenterología

Print version ISSN 0120-9957On-line version ISSN 2500-7440

Rev. colomb. Gastroenterol. vol.39 no.3 Bogotá July/Sept. 2024  Epub Oct 19, 2024

https://doi.org/10.22516/25007440.1172 

Trabajos Originales

Mortality from Colon, Rectal, and Anal Cancer in Barranquilla Between 1985 and 2020

Adalgisa Alcocer-Olaciregui1 
http://orcid.org/0000-0002-9509-8914

Paula Chamorro-Piñeros2 
http://orcid.org/0009-0003-7946-2709

Sara Niño-Castro2 
http://orcid.org/0009-0007-7676-9085

Stefanía Saucedo-Jiménez2 
http://orcid.org/0009-0004-6780-246X

Rusvelt Vargas-Moranth3  * 
http://orcid.org/0000-0002-1014-0969

1 Systems Engineer, Master in Epidemiology. Faculty Member of the Medicine Program, Universidad Libre. Barranquilla, Colombia.

2 Medical Student, Universidad Libre. Barranquilla, Colombia.

3 Physician, Master in Public Health, PhD in Biomedical Sciences, Universidad Libre. Centro Cancerológico del Caribe. Barranquilla, Colombia.


Abstract

Introduction:

Colorectal cancer is the third most common neoplasm worldwide, and Colombia is no exception. It is essential to study mortality from this condition in specific regions, as variations have been found even within the same country. The objective is to describe the mortality trends from colorectal cancer in the district of Barranquilla between 1985 and 2020.

Methodology:

A descriptive and retrospective study. Non-fetal death records with colorectal cancer as the underlying cause of death were analyzed from the National Administrative Department of Statistics (DANE) website for residents in Barranquilla between 1985 and 2020. Crude mortality rates were calculated for the years studied, along with the annual percentage changes in these rates.

Results:

A total of 3,201 deaths from colorectal cancer were recorded, with 59.6% in women and 21.7% in individuals aged 80 years or older. There was an increase in the age-adjusted mortality rate (per 100,000), from 5.1 to 12.7. Overall, there was an upward trend in the annual percentage changes in mortality rates.

Conclusion:

An increase in colorectal cancer mortality was observed in the district of Barranquilla. It is necessary to continue this line of research and investigate factors related to this trend.

Keywords: Mortality; Cancer; Colon; Rectum; Anus

Resumen

Introducción:

El cáncer colorrectal es la tercera neoplasia más frecuente a nivel mundial y Colombia no escapa a esta situación. Es necesario estudiar la mortalidad por esta patología en territorios específicos, ya que se ha encontrado que existen variaciones aún dentro de un mismo país. El objetivo es describir el comportamiento de la mortalidad por cáncer colorrectal en el distrito de Barranquilla entre 1985 y 2020.

Metodología:

Estudio descriptivo y retrospectivo. Se analizaron las actas de defunciones no fetales ocurridas con lugar de residencia en el distrito de Barranquilla entre 1985 y 2020 de la página web del Departamento Administrativo Nacional de Estadística (DANE) con cáncer colorrectal como causa básica de muerte. Se calcularon las tasas crudas de mortalidad para los años estudiados y las variaciones porcentuales anuales de estas tasas.

Resultados:

Se presentaron 3201 fallecimientos por cáncer colorrectal, 59,6% en mujeres y 21,7% en personas de 80 años o más. Hubo un incremento en la tasa de mortalidad ajustada por edad (x 100.000), al pasar de 5,1 a 12,7. En general, hubo un aumento en las variaciones porcentuales anuales de las tasas de mortalidad.

Conclusión:

Se presentó un aumento en la mortalidad por cáncer colorrectal en el distrito de Barranquilla. Es necesario continuar esta línea de investigación e indagar por factores relacionados con este evento.

Palabras clave: Mortalidad; cáncer; colon; recto; ano

Introduction

Colon, rectal, and anal cancer (CRAC) is one of the most significant malignancies worldwide. According to the Global Cancer Observatory (GLOBOCAN), in 2020, there were 1,931,590 new cases, accounting for 10% of global cancer incidence, making it the third most common tumor after breast and lung cancer. Just over 50% of these incident cases occurred in men. Regarding mortality, this cancer accounts for 9.4% of all cancer-related deaths, second only to lung cancer, which accounts for 18%1.

Early detection through screening and the removal of adenomatous polyps2,3, as well as advances in treatment and increased survival rates for CRAC4,5, may partly explain the declining mortality trends in high-income countries6. In contrast, most transitioning countries face significant challenges in achieving such trends due to limited resources, inadequate healthcare infrastructure, and consequently, a lack of effective screening7, along with difficulties in accessing oncology services and appropriate care8.

In Colombia, according to data from the High-Cost Account (CAC in Spanish), colon and rectal cancer ranks as the third most common tumor nationally. In 2019, 3,420 new cases of this pathology were identified, with a distribution of 47.87% in men and 52.13% in women. That same year, 2,384 deaths from colorectal cancer were recorded across Colombia9. In 2012, guidelines for the Integrated Health Care Pathway for the Promotion and Maintenance of Health for the early detection of colon and rectal cancer were introduced in Resolution 4505, later amended by Resolution 3280 in 201810.

In Barranquilla, some risk management indicators tracked by the CAC may be showing challenges in implementing the Integrated Health Care Pathway for the Promotion and Maintenance of Health. The proportion of patients with in situ CRAC is within a low compliance range (1.32%), lower than the national figure of 1.76%11. This highlights the limited intervention in the primary care of the disease and the lack of preventive measures, such as identifying patients with risk factors for developing CRAC and those eligible for diagnostic tests aimed at detecting primary or suggestive lesions of first-degree cancer, such as in situ CRAC.

Given the above, and considering the need to understand mortality trends for CRAC over an extended period, as well as the absence of similar published studies concerning Barranquilla, a key city in the Colombian Caribbean, the aim of this study was to determine the mortality trends from colorectal cancer in the Barranquilla district between 1985 and 2020.

Materials and Methods

This is a descriptive, retrospective study. The study population consisted of non-fetal deaths that occurred in Barranquilla between 1985 and 2020. The sample included all records in which the underlying cause of death was CRAC, from non-fetal deaths occurring in Barranquilla, using ICD-10 codes: C18-C20 and ICD-9 codes: 153.0-154.1. Incomplete records, or those lacking data on sex, age, or habitual residence, were excluded.

The sources of information for the research were secondary. Databases of anonymized non-fetal death records were downloaded from the website of the National Administrative Department of Statistics (DANE). The data were filtered for residents of Barranquilla to obtain the relevant sample. Population projections and retro-projections based on the 2018 DANE Census were also downloaded for the years covered in the study. Age-adjusted mortality rates were calculated using the direct method, with the SEGI population as the reference12. The relative variation of the age-adjusted mortality rate was calculated by year.

This research was approved by the Ethics Committee of Universidad Libre, Barranquilla branch. It is supported by the legal framework of Resolution 8430 of 1993, Article 5, which primarily considers the criteria of respect, dignity, and protection of human rights. According to this classification, the present study is risk-free, as it only involves retrospective documentary research techniques and methods13.

Results

A total of 3,201 deaths from colorectal cancer (CRC) occurred during the observation period. In both men and women, the number of deaths increased over the years. In 1985, 28 deaths were recorded, while in 2006, the numbers surpassed 100; in 2017, the figure reached 208, with a peak of 214 deaths occurring in 2020. Also, in most years, the percentage of cases was higher among women, reaching its peak in 2008 with 69.2% (Figure 1).

Figure 1 Percentage distribution of deaths from colon, rectal, and anal cancer in Barranquilla between 1985 and 2020, by sex. Prepared by the authors using DANE, Vital Statistics data. 

Regarding the distribution by age groups (Figure 2), a trend of increasing deaths was found as age increased, with a peak in those over 80 years old, representing 21.74% of the deaths. It is noteworthy that the age group 15 to 19 years had a percentage of 5.62%.

Figure 2 Percentage distribution of deaths from colon, rectal, and anal cancer in Barranquilla between 1985 and 2020, by age groups. Prepared by the authors using DANE, Vital Statistics data. 

In terms of the age-adjusted mortality rate for CRC, 2017 recorded the highest rate, with 13.8 deaths per 100,000 inhabitants. This year also showed the highest mortality rate among women during the study period, with 13.26 deaths per 100,000 women. Among men, the highest rate was recorded in 2020, with 17.2 deaths per 100,000 (Table 1).

Table 1 Age-adjusted mortality rates (AAMR) for colon, rectal, and anal cancer in Barranquilla between 1985 and 2020 

Year Age-Adjusted Rate per 100,000 Year Age-Adjusted Rate per 100,000
Men Women Total Men Women Total
1985 5.74 4.60 5.11 2003 9.39 7.05 8.10
1986 6.56 5.54 6.01 2004 7.33 8.34 7.91
1987 3.91 3.36 3.63 2005 5.79 5.37 5.59
1988 4.16 3.66 3.86 2006 7.48 10.38 8.98
1989 5.92 7.11 6.62 2007 6.87 7.83 7.45
1990 4.32 5.12 4.74 2008 6.44 10.87 9.00
1991 3.80 7.18 5.66 2009 9.29 9.44 9.38
1992 5.58 3.48 4.41 2010 7.54 9.63 8.71
1993 6.90 5.97 6.39 2011 7.14 6.79 6.92
1994 6.94 7.55 7.24 2012 11.15 8.48 9.66
1995 5.96 6.85 6.47 2013 8.16 8.17 8.18
1996 7.40 5.52 6.41 2014 12.63 8.74 10.42
1997 8.93 6.61 7.60 2015 9.15 11.38 10.41
1998 9.22 5.92 7.39 2016 12.62 10.31 11.32
1999 7.84 8.14 8.10 2017 14.74 13.26 13.88
2000 7.05 8.38 7.89 2018 14.60 11.98 13.16
2001 6.20 6.25 6.22 2019 12.70 10.89 11.60
2002 6.64 6.97 6.90 2020 17.21 9.39 12.68

Prepared by the authors using DANE, Vital Statistics data.

The mortality rate showed an increase of 147.4% between 1985 and 2020. Regarding the annual percentage changes in mortality (Figure 3), there was an increase, particularly between 1988 and 1989, with a 71.8% rise. On the other hand, the largest decrease occurred between 1986 and 1987, with a negative variation of 39.6%.

Figure 3 Annual percentage changes (APC) (%) in mortality from colon, rectal, and anal cancer in Barranquilla between 1985 and 2020. Prepared by the authors using DANE, Vital Statistics data. 

Discussion

The analysis of CRAC incidence worldwide reveals a significant increase over the years, which has been linked to various factors such as dietary habits, obesity, tobacco and alcohol consumption, and lack of physical activity, among others14.

Despite this rise in incidence, it is interesting to note that it does not always directly translate into a higher mortality rate. According to Wong and colleagues15, mortality can be significantly influenced by access to early detection services and advanced therapies. This finding is supported by Breugom and collaborators16, who demonstrated that in Europe, the mortality rate has decreased thanks to improvements in staging, access to effective treatments, standardization of care, and the implementation of surgical audits.

In contrast to these results, a different scenario emerges in Barranquilla. Firstly, there is a notable trend of a steady increase in the number of deaths throughout the study period, which may be attributed to various determinants, ranging from changes in detection and diagnostic patterns to possible risk factors within the population.

Another notable finding is the higher predisposition of women to die from CRC. In 2008, the highest number of deaths among females was recorded. However, it is important to note that this predisposition does not remain consistent over time. By age group, there is a trend of increasing risk of death as age advances, similar to global patterns15, which underscores the importance of early detection and medical care in older adult populations. Surprisingly, the age group of 15 to 19 years also shows a significant percentage. This unusual finding warrants further investigation to better understand its underlying causes.

Despite efforts and strategies implemented by the Colombian government through the Ministry of Health to improve the situation, mortality has continued to rise in this city. This raises questions about the effectiveness of the measures taken. Risk management indicators show a low percentage of patients with CRAC classified as in situ (1.32%), and only 75.76% of patients are stratified according to the TNM staging system. These, along with other indicators, highlight the difficulties in implementing the Integrated Health Care Pathway for the Promotion and Maintenance of Health. This suggests that medical care in Barranquilla may not be meeting the desired standards.

However, determining the reasons for the increase in mortality in the city is beyond the scope of this study. Particularly, with a steady rise in the number of deaths throughout the study period, a variety of factors could be involved, ranging from changes in detection and diagnostic patterns to potential risk factors in the population. Therefore, it is considered appropriate to link mortality with rates of premalignant lesions, the number of units equipped to provide early detection and diagnostic services, the percentages of colonoscopies ordered and performed, the timeliness of care, and the level of knowledge among healthcare professionals on the subject.

Additionally, the type of treatment received should be reviewed, as mortality increases when surgery is the only option available without complementary therapy17-19. Delays in diagnosis, referral, and treatment, along with cultural beliefs and financial limitations, can also account for most of the mortality20.

As a limitation, it is important to mention that there may have been underreporting of mortality, especially in the early years studied, when a death certificate was not required to access funeral services. Additionally, it should be noted that population-based indicators require knowledge of the number of individuals in the area. Population censuses are a mechanism to determine the number of inhabitants; however, due to the costs involved, the country conducts them every ten years. Projections are made based on this data to estimate population sizes until a new census is conducted, and these projections are adjusted with retro-projections based on past censuses. These changes affect the behavior of the indicators, as the risk estimates, such as mortality from CRAC, could be under- or overestimated prior to census adjustments.

Conclusions

The global increase in the incidence of CRAC and its relationship with various risk factors highlights the importance of early detection strategies and advanced treatments. However, despite governmental efforts, mortality from CRAC in Barranquilla has increased, potentially indicating deficiencies in healthcare and in the implementation of disease prevention and control programs.

Overall, these results provide a comprehensive picture of the evolution of CRC mortality in Barranquilla over the decades. These findings could be critical for formulating public health strategies focused on early detection and education about the disease across all age groups and sexes.

Referencias

1. Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021; 71(3):209-249. https://doi.org/10.3322/caac.21660Links ]

2. Shaukat A, Kahi C, Burke C, Rabeneck L, Sauer B, Rex D. ACG clinical guidelines: colorectal cancer screening 2021. Am J Gastroenterol. 2021;116(3):458-479. https://doi.org/10.14309/ajg.0000000000001122Links ]

3. Davidson K, Barry M, Mangione C, Cabana M, Caughey A, Davis E, et al. Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. JAMA. 2021;325(19):1965-1977. https://doi.org/10.1001/jama.2021.6238Links ]

4. Rawla P, Sunkara T, Barsouk A. Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors. Prz Gastroenterol. 2019;14(2):89-103. https://doi.org/10.5114/pg.2018.81072Links ]

5. Biller L, Schrag D. Diagnosis and treatment of metastatic colorectal cancer: a review. JAMA. 2021;325(7):669-685. https://doi.org/10.1001/jama.2021.0106Links ]

6. Araghi M, Soerjomataram I, Bardot A, Ferlay J, Cabasag C, Morrison D, et al. Changes in colorectal cancer incidence in seven high-income countries: a population-based study. Lancet Gastroenterol Hepatol. 2019;4(7):511-518. https://doi.org/10.1016/S2468-1253(19)30147-5Links ]

7. Carethers J, Doubeni C. Causes of socioeconomic disparities in colorectal cancer and intervention framework and strategies. Gastroenterology. 2020;158(2):354-367. https://doi.org/10.1053/j.gastro.2019.10.029Links ]

8. Sharma R. An examination of colorectal cancer burden by socioeconomic status: evidence from GLOBOCAN 2018. EPMA J. 2020;11(1):95-117. https://doi.org/10.1007/s13167-019-00185-yLinks ]

9. Cuenta de Alto Costo. HIGIA, Indicadores de la gestión del riesgo [Internet]. CAC; 2023 [consultado el 3 de marzo de 2023]. Disponible en: Disponible en: https://cuentadealtocosto.org/investigaciones/boletin-3-indicadores-de-la-gestion-del-riesgo/Links ]

10. Ministerio de Salud y Protección Social. Resolución 3280 de 2018, por medio de la cual se adoptan los lineamientos técnicos y operativos de la Ruta Integral de Atención para la Promoción y Mantenimiento de la Salud y la Ruta Integral de Atención en Salud para la Población Materno Perinatal y se establecen las directrices para su operación. Colombia: Ministerio de Salud y Protección social; 2018. [ Links ]

11. Cuenta de Alto Costo. HIGIA, Indicadores demográficos [Internet] CAC; 2023 [consultado el 3 de marzo de 2023]. Disponible en: Disponible en: https://cuentadealtocosto.org/site/higia/cancer-indicadores-demografico/Links ]

12. Organización Panamericana de la Salud. La Estandarización: Un Método Epidemiológico Clásico para la Comparación de Tasas. Boletín Epidemiológico. 2002;23(3):9-12. [ Links ]

13. Ministerio de Salud y Protección Social. Resolución Número 8430 de 1993, por la cual se establecen las normas científicas, técnicas y administrativas para la investigación en salud. Colombia: Ministerio de Salud; 1993. [ Links ]

14. Araghi M, Soerjomataram I, Jenkins M, Brierley J, Morris E, Bray F, et al. Global trends in colorectal cancer mortality: projections to the year 2035. Int J Cancer. 2019;144(12):2992-3000. https://doi.org/10.1002/ijc.32055Links ]

15. Wong M, Huang J, Lok V, Wang J, Fung F, Ding H, et al. Differences in incidence and mortality trends of colorectal cancer worldwide based on sex, age, and anatomic location. Clin Gastroenterol Hepatol. 2021;19(5):955-966. https://doi.org/10.1016/j.cgh.2020.02.026Links ]

16. Breugom A, Bastiaannet E, Dekker JWT, Wouters MWJM, van de Velde CJH, Liefers GJ. Decrease in 30-day and one-year mortality over time in patients aged ≥75 years with stage I-III colon cancer: A population-based study. Eur J Surg Oncol. 2018;44(12):1889-1893. https://doi.org/10.1016/j.ejso.2018.08.010Links ]

17. Shi J, Sun Z, Gao Z, Huang D, Hong H, Gu J. Radioimmunotherapy in colorectal cancer treatment: present and future. Front Immunol. 2023;14(1):1105180. https://doi.org/10.3389/fimmu.2023.1105180Links ]

18. Sveen A, Kopetz S, Lothe R. Biomarker-guided therapy for colorectal cancer: strength in complexity. Nat Rev Clin Oncol. 2020; 17(1): 11-32. https://doi.org/10.1038/s41571-019-0241-1Links ]

19. Hossain M, Karuniawati H, Jairoun A, Urbi Z, Ooi D, John A, et al. Colorectal cancer: a review of carcinogenesis, global epidemiology, current challenges, risk factors, preventive and treatment strategies. Cancers (Basel). 2022;14(7):1732. https://doi.org/10.3390/cancers14071732Links ]

20. Barrios C, Werutsky G, Mohar A, Ferrigno A, Müller B, Bychkovsky B, et al. Cancer control in Latin America and the Caribbean: recent advances and opportunities to move forward. Lancet Oncol. 2021;22(11):e474-e487. https://doi.org/10.1016/S1470-2045(21)00492-7Links ]

Citación: Alcocer-Olaciregui A, Chamorro-Piñeros P, Niño-Castro S, Saucedo-Jiménez S, Vargas-Moranth R. Mortalidad por cáncer de colon, recto y ano en Barranquilla entre 1985 y 2020. Revista. colomb. Gastroenterol. 2024;39(3):260-266. https://doi.org/10.22516/25007440.1172

Received: January 19, 2024; Accepted: April 22, 2024

*Correspondencia: Rusvelt Vargas-Moranth. rusphd@gmail.com

Creative Commons License This is an open-access article distributed under the terms of the Creative Commons Attribution License